ID   IFNG_HUMAN              Reviewed;         166 AA.
AC   P01579; B5BU88; Q53ZV4;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1988, sequence version 1.
DT   21-MAR-2012, entry version 143.
DE   RecName: Full=Interferon gamma;
DE            Short=IFN-gamma;
DE   AltName: Full=Immune interferon;
DE   Flags: Precursor;
GN   Name=IFNG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=82272342; PubMed=6180322; DOI=10.1038/298859a0;
RA   Gray P.W., Goeddel D.V.;
RT   "Structure of the human immune interferon gene.";
RL   Nature 298:859-863(1982).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=82125473; PubMed=6173769; DOI=10.1038/295503a0;
RA   Gray P.W., Leung D.W., Pennica D., Yelverton E., Najarian R.,
RA   Simonsen C.C., Derynck R., Sherwood P.J., Wallace D.M., Berger S.L.,
RA   Levinson A.D., Goeddel D.V.;
RT   "Expression of human immune interferon cDNA in E. coli and monkey
RT   cells.";
RL   Nature 295:503-508(1982).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=85207508; PubMed=2860101;
RA   Nishi T., Fujita T., Nishi-Takaoka C., Saito A., Matsumoto T.,
RA   Sato M., Oka T., Itoh S., Yip Y.K., Vilcek J., Taniguchi T.;
RT   "Cloning and expression of a novel variant of human interferon-gamma
RT   cDNA.";
RL   J. Biochem. 97:153-159(1985).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=84236074; PubMed=6329718;
RA   Taya Y., Devos R., Tavernier J., Cheroutre H., Engler G., Fiers W.;
RT   "Cloning and structure of the human immune interferon-gamma
RT   chromosomal gene.";
RL   EMBO J. 1:953-958(1982).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=82196887; PubMed=6176945; DOI=10.1093/nar/10.8.2487;
RA   Devos R., Cheroutre H., Taya Y., Degrave W., van Heuverswyn H.,
RA   Fiers W.;
RT   "Molecular cloning of human immune interferon cDNA and its expression
RT   in eukaryotic cells.";
RL   Nucleic Acids Res. 10:2487-2501(1982).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-160.
RA   Chikara S.K., Jaiswal P., Sharma G.;
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 24-157, AND GLYCOSYLATION AT ASN-48 AND ASN-120.
RX   MEDLINE=84212517; PubMed=6427223;
RA   Rinderknecht E., O'Conner B.H., Rodriguez H.;
RT   "Natural human interferon-gamma. Complete amino acid sequence and
RT   determination of sites of glycosylation.";
RL   J. Biol. Chem. 259:6790-6797(1984).
RN   [12]
RP   PROTEIN SEQUENCE OF 24-161, AND PROTEOLYTIC PROCESSING OF THE
RP   C-TERMINUS.
RX   MEDLINE=87246669; PubMed=3109913;
RX   DOI=10.1111/j.1432-1033.1987.tb13494.x;
RA   Pan Y.C.E., Stern A.S., Familletti P.C., Khan F.R., Chizzonite R.;
RT   "Structural characterization of human interferon gamma. Heterogeneity
RT   of the carboxyl terminus.";
RL   Eur. J. Biochem. 166:145-149(1987).
RN   [13]
RP   STRUCTURE OF CARBOHYDRATES.
RX   MEDLINE=89359197; PubMed=2504704;
RA   Yamamoto S., Hase S., Yamauchi H., Tanimoto T., Ikenaka T.;
RT   "Studies on the sugar chains of interferon-gamma from human
RT   peripheral-blood lymphocytes.";
RL   J. Biochem. 105:1034-1039(1989).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS).
RX   MEDLINE=91220068; PubMed=1902591; DOI=10.1126/science.1902591;
RA   Ealick S.E., Cook W.J., Vijay-Kumar S., Carson M., Nagabhushan T.L.,
RA   Trotta P.P., Bugg C.E.;
RT   "Three-dimensional structure of recombinant human interferon-gamma.";
RL   Science 252:698-702(1991).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS).
RX   MEDLINE=95342235; PubMed=7617032; DOI=10.1038/376230a0;
RA   Walter M.R., Windsor W.T., Nagabhushan T.L., Lundell D.J., Lunn C.A.,
RA   Zauodny P.J., Narula S.K.;
RT   "Crystal structure of a complex between interferon-gamma and its
RT   soluble high-affinity receptor.";
RL   Nature 376:230-235(1995).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS).
RX   MEDLINE=20328607; PubMed=10860730; DOI=10.1006/jmbi.2000.3734;
RA   Landar A., Curry B., Parker M.H., DiGiacomo R., Indelicato S.R.,
RA   Nagabhushan T.L., Rizzi G., Walter M.R.;
RT   "Design, characterization, and structure of a biologically active
RT   single-chain mutant of human IFN-gamma.";
RL   J. Mol. Biol. 299:169-179(2000).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF COMPLEX WITH RECEPTOR.
RX   PubMed=10986460; DOI=10.1016/S0969-2126(00)00184-2;
RA   Thiel D.J., le Du M.-H., Walter R.L., D'Arcy A., Chene C.,
RA   Fountoulakis M., Garotta G., Winkler F.K., Ealick S.E.;
RT   "Observation of an unexpected third receptor molecule in the crystal
RT   structure of human interferon-gamma receptor complex.";
RL   Structure 8:927-936(2000).
RN   [18]
RP   STRUCTURE BY NMR.
RX   MEDLINE=92399429; PubMed=1525157; DOI=10.1021/bi00150a009;
RA   Grzesiek S., Doebeli H., Gentz R., Garotta G., Labhardt A.M., Bax A.;
RT   "1H, 13C, and 15N NMR backbone assignments and secondary structure of
RT   human interferon-gamma.";
RL   Biochemistry 31:8180-8190(1992).
RN   [19]
RP   ASSOCIATION WITH APLASTIC ANEMIA.
RX   PubMed=15327519; DOI=10.1111/j.1365-2141.2004.05102.x;
RA   Dufour C., Capasso M., Svahn J., Marrone A., Haupt R., Bacigalupo A.,
RA   Giordani L., Longoni D., Pillon M., Pistorio A., Di Michele P.,
RA   Iori A.P., Pongiglione C., Lanciotti M., Iolascon A.;
RT   "Homozygosis for (12) CA repeats in the first intron of the human IFN-
RT   gamma gene is significantly associated with the risk of aplastic
RT   anaemia in Caucasian population.";
RL   Br. J. Haematol. 126:682-685(2004).
CC   -!- FUNCTION: Produced by lymphocytes activated by specific antigens
CC       or mitogens. IFN-gamma, in addition to having antiviral activity,
CC       has important immunoregulatory functions. It is a potent activator
CC       of macrophages, it has antiproliferative effects on transformed
CC       cells and it can potentiate the antiviral and antitumor effects of
CC       the type I interferons.
CC   -!- SUBUNIT: Homodimer.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Released primarily from activated T
CC       lymphocytes.
CC   -!- PTM: Proteolytic processing produces C-terminal heterogeneity,
CC       with proteins ending alternatively at Gly-150, Met-157 or Gly-161.
CC   -!- DISEASE: In Caucasians, genetic variation in IFNG is associated
CC       with the risk of aplastic anemia (AA) [MIM:609135]. AA is a rare
CC       disease in which the reduction of the circulating blood cells
CC       results from damage to the stem cell pool in bone marrow. In most
CC       patients, the stem cell lesion is caused by an autoimmune attack.
CC       T-lymphocytes, activated by an endogenous or exogenous, and most
CC       often unknown antigenic stimulus, secrete cytokines, including
CC       IFN-gamma, which would in turn be able to suppress hematopoiesis.
CC   -!- PHARMACEUTICAL: Available under the name Actimmune (Genentech).
CC       Used for reducing the frequency and severity of serious infections
CC       associated with chronic granulomatous disease (CGD).
CC   -!- SIMILARITY: Belongs to the type II (or gamma) interferon family.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/IFNG";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Interferon gamma entry;
CC       URL="http://en.wikipedia.org/wiki/Interferon_gamma";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/ifng/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X13274; CAA31639.1; -; mRNA.
DR   EMBL; J00219; AAB59534.1; -; Genomic_DNA.
DR   EMBL; X01992; CAA26022.1; -; mRNA.
DR   EMBL; V00543; CAA23804.1; -; mRNA.
DR   EMBL; AY255837; AAP20098.1; -; mRNA.
DR   EMBL; AF375790; AAK53058.1; -; Genomic_DNA.
DR   EMBL; AB451324; BAG70138.1; -; mRNA.
DR   EMBL; AB451453; BAG70267.1; -; mRNA.
DR   EMBL; CH471054; EAW97180.1; -; Genomic_DNA.
DR   EMBL; BC070256; AAH70256.1; -; mRNA.
DR   IPI; IPI00307209; -.
DR   PIR; A93284; IVHUG.
DR   RefSeq; NP_000610.2; NM_000619.2.
DR   UniGene; Hs.856; -.
DR   PDB; 1EKU; X-ray; 2.90 A; A/B=26-161.
DR   PDB; 1FG9; X-ray; 2.90 A; A/B=24-156.
DR   PDB; 1FYH; X-ray; 2.04 A; A/D=24-156.
DR   PDB; 1HIG; X-ray; 3.50 A; A/B/C/D=24-161.
DR   PDB; 3BES; X-ray; 2.20 A; L=24-161.
DR   PDBsum; 1EKU; -.
DR   PDBsum; 1FG9; -.
DR   PDBsum; 1FYH; -.
DR   PDBsum; 1HIG; -.
DR   PDBsum; 3BES; -.
DR   ProteinModelPortal; P01579; -.
DR   SMR; P01579; 24-155.
DR   DIP; DIP-483N; -.
DR   IntAct; P01579; 2.
DR   STRING; P01579; -.
DR   GlycoSuiteDB; P01579; -.
DR   PhosphoSite; P01579; -.
DR   DMDM; 124479; -.
DR   PRIDE; P01579; -.
DR   DNASU; 3458; -.
DR   Ensembl; ENST00000229135; ENSP00000229135; ENSG00000111537.
DR   GeneID; 3458; -.
DR   KEGG; hsa:3458; -.
DR   UCSC; uc001stw.1; human.
DR   CTD; 3458; -.
DR   GeneCards; GC12M068548; -.
DR   H-InvDB; HIX0036727; -.
DR   HGNC; HGNC:5438; IFNG.
DR   HPA; CAB010344; -.
DR   MIM; 147570; gene.
DR   MIM; 609135; phenotype.
DR   neXtProt; NX_P01579; -.
DR   Orphanet; 88; Idiopathic aplastic anemia.
DR   PharmGKB; PA29674; -.
DR   eggNOG; NOG45353; -.
DR   GeneTree; ENSGT00390000007831; -.
DR   HOGENOM; HBG127262; -.
DR   HOVERGEN; HBG056912; -.
DR   InParanoid; P01579; -.
DR   KO; K04687; -.
DR   OMA; KEYFNAS; -.
DR   OrthoDB; EOG4MCX1G; -.
DR   PhylomeDB; P01579; -.
DR   Pathway_Interaction_DB; nfat_tfpathway; Calcineurin-regulated NFAT-dependent transcription in lymphocytes.
DR   Pathway_Interaction_DB; tcrcalciumpathway; Calcium signaling in the CD4+ TCR pathway.
DR   Pathway_Interaction_DB; cd8tcrdownstreampathway; Downstream signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; ifngpathway; IFN-gamma pathway.
DR   Pathway_Interaction_DB; il12_stat4pathway; IL12 signaling mediated by STAT4.
DR   Pathway_Interaction_DB; il12_2pathway; IL12-mediated signaling events.
DR   Pathway_Interaction_DB; il2_1pathway; IL2-mediated signaling events.
DR   Pathway_Interaction_DB; il23pathway; IL23-mediated signaling events.
DR   Pathway_Interaction_DB; il27pathway; IL27-mediated signaling events.
DR   Pathway_Interaction_DB; pdgfrapathway; PDGFR-alpha signaling pathway.
DR   Pathway_Interaction_DB; telomerasepathway; Regulation of Telomerase.
DR   Reactome; REACT_6900; Immune System.
DR   DrugBank; DB01296; Glucosamine.
DR   DrugBank; DB00033; Interferon gamma-1b.
DR   DrugBank; DB00641; Simvastatin.
DR   NextBio; 13624; -.
DR   PMAP-CutDB; P01579; -.
DR   ArrayExpress; P01579; -.
DR   Bgee; P01579; -.
DR   CleanEx; HS_IFNG; -.
DR   Genevestigator; P01579; -.
DR   GermOnline; ENSG00000111537; Homo sapiens.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0005133; F:interferon-gamma receptor binding; TAS:ProtInc.
DR   GO; GO:0007050; P:cell cycle arrest; IDA:BHF-UCL.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0032700; P:negative regulation of interleukin-17 production; IDA:BHF-UCL.
DR   GO; GO:0003340; P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0072308; P:negative regulation of metanephric nephron tubule epithelial cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0060559; P:positive regulation of calcidiol 1-monooxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0060550; P:positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity; IDA:BHF-UCL.
DR   GO; GO:0060552; P:positive regulation of fructose 1,6-bisphosphate metabolic process; IDA:BHF-UCL.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; IDA:UniProtKB.
DR   GO; GO:0032747; P:positive regulation of interleukin-23 production; IDA:BHF-UCL.
DR   GO; GO:0051712; P:positive regulation of killing of cells of other organism; IDA:BHF-UCL.
DR   GO; GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IDA:BHF-UCL.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:BHF-UCL.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0045672; P:positive regulation of osteoclast differentiation; IDA:BHF-UCL.
DR   GO; GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; NAS:BHF-UCL.
DR   GO; GO:0034393; P:positive regulation of smooth muscle cell apoptosis; IDA:BHF-UCL.
DR   GO; GO:2000309; P:positive regulation of tumor necrosis factor (ligand) superfamily member 11 production; IDA:BHF-UCL.
DR   GO; GO:0042511; P:positive regulation of tyrosine phosphorylation of Stat1 protein; IDA:BHF-UCL.
DR   GO; GO:0060557; P:positive regulation of vitamin D biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0000060; P:protein import into nucleus, translocation; IDA:UniProtKB.
DR   GO; GO:0050796; P:regulation of insulin secretion; IDA:BHF-UCL.
DR   GO; GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0009615; P:response to virus; IDA:MGI.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR012351; 4_helix_cytokine_core.
DR   InterPro; IPR002069; Interferon_gamma.
DR   Gene3D; G3DSA:1.20.1250.10; 4_helix_cytokine_core; 1.
DR   PANTHER; PTHR11419; IFN-gamma; 1.
DR   Pfam; PF00714; IFN-gamma; 1.
DR   PIRSF; PIRSF001936; IFN-gamma; 1.
DR   ProDom; PD002435; Interferon_gamma; 1.
DR   SUPFAM; SSF47266; 4_helix_cytokine; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antiviral defense; Cleavage on pair of basic residues;
KW   Complete proteome; Cytokine; Direct protein sequencing; Glycoprotein;
KW   Growth regulation; Pharmaceutical; Polymorphism;
KW   Pyrrolidone carboxylic acid; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     23
FT   CHAIN        24    161       Interferon gamma.
FT                                /FTId=PRO_0000016444.
FT   PROPEP      162    166
FT                                /FTId=PRO_0000259481.
FT   MOD_RES      24     24       Pyrrolidone carboxylic acid.
FT   CARBOHYD     48     48       N-linked (GlcNAc...).
FT   CARBOHYD    120    120       N-linked (GlcNAc...); in dimeric form.
FT   VARIANT      29     29       K -> Q.
FT                                /FTId=VAR_004017.
FT   VARIANT     160    160       R -> Q.
FT                                /FTId=VAR_004018.
FT   HELIX         2     18
FT   HELIX        25     38
FT   HELIX        53     58
FT   HELIX        62     81
FT   TURN         82     85
FT   TURN         87     89
FT   HELIX        90    104
FT   HELIX       109    119
FT   HELIX       126    140
SQ   SEQUENCE   166 AA;  19348 MW;  1514E8F785FD81AA CRC64;
     MKYTSYILAF QLCIVLGSLG CYCQDPYVKE AENLKKYFNA GHSDVADNGT LFLGILKNWK
     EESDRKIMQS QIVSFYFKLF KNFKDDQSIQ KSVETIKEDM NVKFFNSNKK KRDDFEKLTN
     YSVTDLNVQR KAIHELIQVM AELSPAAKTG KRKRSQMLFR GRRASQ
//
